18F-FDG is the PET tracer most commonly used in nuclear medicine today. 18F-FDG is a structurally poorly altered, radioactively labeled sugar. After injection into the body, the tracer is distributed in the tissue and is taken up by cells that have a high turnover of sugar (e.g. the brain). If the accumulation in the brain is too low, e.g. in dementia or epilepsy, PET / CT or PET / MR can be used to determine.
Distribution of the tracer 18F-FDG in the brain.
The following indications are reimbursed by the health insurance:
Senior Attending Physician, Department of Nuclear Medicine
Deputy Clinic Director, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Diagnostic Neuroradiologist, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Senior Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Neuroradiologist, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.
Simply assign your patient via registration form.
Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02